Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection
2016
Williams, John R. | Tenforde, Mark W. | Chan, Jeannie D. | Ko, Andrew | Graham, Susan M.
We present a 71-year old woman treated with 14 days of 5mg intraventricular caspofungin for Scedosporium apiospermum complex meningoencephalitis diagnosed after spinal fusion and instrumentation. Cerebrospinal fluid studies improved during therapy and intraventricular administration was well tolerated. Within weeks of discontinuation, the patient experienced clinical deterioration with disease progression. There are sparse data on the efficacy and safety of administering intraventricular caspofungin. While apparently safe, intraventricular caspofungin was insufficient for disease control in this case.
Показать больше [+] Меньше [-]Ключевые слова АГРОВОК
Библиографическая информация
Эту запись предоставил National Agricultural Library